Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

MRK

Merck & Co Inc

Apr 24 • 04:00PM ET

127.00

Dollar change +0.12
Percentage change 0.09	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VOO IVV VTV VIG VYM VHT IWD DGRO HDV

Index	DJIA, S&P 500	P/E	960.67	EPS (ttm)	0.13	Insider Own	0.16%	Shs Outstand	2.53B	Perf Week	1.30%
Market Cap	321.65B	Forward P/E	12.94	EPS next Y	9.81	Insider Trans	-10.71%	Shs Float	2.53B	Perf Month	1.35%
Income	365.00M	PEG	14.26	EPS next Q	1.90	Inst Own	78.69%	Short Float	0.77%	Perf Quarter	6.83%
Sales	59.87B	P/S	5.37	EPS this Y	466.79%	Inst Trans	0.64%	Short Ratio	2.36	Perf Half Y	22.88%
Book/sh	14.84	P/B	8.56	EPS next Y	14.63%	ROA	0.34%	Short Interest	19.59M	Perf Year	9.54%
Cash/sh	2.83	P/C	44.92	EPS next 5Y	67.38%	ROE	0.87%	52W Range	99.14 - 133.10	Perf YTD	16.49%
Dividend Est.	3.23 (2.54%)	P/FCF	35.18	EPS past 5Y	-42.70%	ROI	0.51%	52W High	-4.58%	Beta	0.41
Dividend TTM	3.00 (2.36%)	Quick Ratio	1.00	Sales past 5Y	7.72%	Gross Margin	70.37%	52W Low	28.10%	ATR (14)	1.95
Dividend Ex-Date	Mar 14, 2024	Current Ratio	1.25	EPS Y/Y TTM	-97.48%	Oper. Margin	5.08%	RSI (14)	54.28	Volatility	1.23% 1.46%
Employees	72000	Debt/Eq	0.97	Sales Y/Y TTM	2.39%	Profit Margin	0.61%	Recom	1.55	Target Price	138.26
Option/Short	Yes / Yes	LT Debt/Eq	0.92	EPS Q/Q	-140.87%	Payout	2065.60%	Rel Volume	0.85	Prev Close	126.88
Sales Surprise	0.97%	EPS Surprise	127.65%	Sales Q/Q	13.82%	Earnings	Apr 25 BMO	Avg Volume	8.32M	Price	127.00
SMA20	-0.37%	SMA50	0.75%	SMA200	12.59%	Trades		Volume	7,084,991	Change	0.09%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-11-24	Downgrade	Societe Generale	Hold → Sell	$104
Jan-04-24	Upgrade	TD Cowen	Market Perform → Outperform	$125 → $135
Nov-09-23	Initiated	Deutsche Bank	Buy	$115
Oct-27-23	Upgrade	BMO Capital Markets	Market Perform → Outperform	$132
Oct-20-23	Upgrade	UBS	Neutral → Buy	$117 → $122
Jul-14-23	Initiated	HSBC Securities	Hold	$123
Apr-13-23	Upgrade	Citigroup	Neutral → Buy	$105 → $130
Mar-28-23	Downgrade	Societe Generale	Buy → Hold
Mar-13-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$120 → $115
Mar-06-23	Initiated	Jefferies	Buy	$125
Feb-22-23	Upgrade	Wolfe Research	Peer Perform → Outperform	$127
Jan-04-23	Upgrade	BofA Securities	Neutral → Buy	$110 → $130
Nov-18-22	Initiated	Credit Suisse	Outperform	$120
Oct-10-22	Upgrade	Guggenheim	Neutral → Buy
Sep-14-22	Upgrade	Berenberg	Hold → Buy	$95 → $100
Jul-06-22	Upgrade	Daiwa Securities	Neutral → Buy	$89 → $102
Jun-06-22	Resumed	SVB Leerink	Outperform	$102
Apr-06-22	Resumed	Morgan Stanley	Equal-Weight	$80
Dec-17-21	Initiated	Goldman	Buy	$93
Dec-16-21	Initiated	Daiwa Securities	Neutral	$70

Show Previous Ratings

Today 05:50PM	Alphabet, Microsoft, Southwest earnings: What to watch (Yahoo Finance Video)
Apr-23-24 07:49AM	Here's Why Merck & Co. (MRK) Outperformed in Q1 (Insider Monkey)
Apr-22-24 02:39PM	How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings? (Zacks)
11:10AM	10 Best Performing Biotech ETFs in 2024 (Insider Monkey)
09:15AM	Exploring Analyst Estimates for Merck (MRK) Q1 Earnings, Beyond Revenue and EPS (Zacks)
10:49AM	Loading…
Apr-21-24 10:49AM	11 Hot Growth Stocks To Buy Right Now (Insider Monkey)
Apr-19-24 07:04AM	Health Canada Approves KEYTRUDA® as a first-line treatment for adult patients with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma in combination with fluoropyrimidine- and platinum-containing chemotherapy (PR Newswire)
Apr-18-24 04:27PM	13 Best Low Volatility Stocks to Buy According to Hedge Funds (Insider Monkey)
10:01AM	Merck (MRK) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Apr-17-24 05:50PM	Merck (MRK) Advances While Market Declines: Some Information for Investors (Zacks)
08:00AM	Coming FDA Approvals Could Send These 3 Drug Stocks Soaring (InvestorPlace)
Apr-16-24 03:17PM	3 Dow Stocks to Buy Now: Q2 Edition (InvestorPlace)
Apr-15-24 07:48AM	10 Best Low Volatility ETFs To Buy (Insider Monkey)
Apr-12-24 06:40AM	7 A-Rated Aggressive Biotech Stocks to Bet On in 2024 (InvestorPlace)
Apr-11-24 05:50PM	Merck (MRK) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
11:38PM	Loading…
Apr-08-24 11:38PM	Merck (MRK) Begins Phase II/II Ovarian Cancer Study on ADC Drug (Revised) (Zacks)
02:00PM	Golden Years Gainers: 3 Stocks to Fund Your Dream Retirement (InvestorPlace)
Apr-07-24 02:00PM	The 3 Most Undervalued S&P 500 Stocks to Buy in April 2024 (InvestorPlace)
Apr-06-24 08:47PM	10 Best Weight Loss Drug Stocks to Buy Now (Insider Monkey)
Apr-05-24 05:45PM	Merck (MRK) Rises Yet Lags Behind Market: Some Facts Worth Knowing (Zacks)
05:33AM	Merck (MRK) Begins Phase III NSCLC Study on KRAS Candidate (Zacks)
Apr-04-24 07:38AM	Merck puts KRAS cancer drug competitor to the test (BioPharma Dive)
06:45AM	Merck Initiates Phase 3 Clinical Trial of MK-1084, an Investigational Oral KRAS G12C Inhibitor, in Combination with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Certain Patients With Metastatic Non-Small Cell Lung Cancer (Business Wire)
05:36AM	Merck (MRK) Begins Phase II/II Ovarian Cancer Study on ADC Drug (Zacks)
Apr-03-24 05:50PM	Merck (MRK) Stock Sinks As Market Gains: What You Should Know (Zacks)
08:00AM	REJOICE-Ovarian01 Phase 2/3 Trial of Raludotatug Deruxtecan Initiated in Patients with Platinum-Resistant Ovarian Cancer (Business Wire)
Apr-01-24 09:50AM	Why Merck (MRK) is a Top Momentum Stock for the Long-Term (Zacks)
06:45AM	Merck to Hold First-Quarter 2024 Sales and Earnings Conference Call April 25 (Business Wire)
Mar-29-24 10:51AM	3 Strong Buy Healthcare Stocks to Add to Your Q2 Must-Watch List (InvestorPlace)
Mar-28-24 05:50PM	Merck (MRK) Rises Higher Than Market: Key Facts (Zacks)
09:15AM	Loading…
09:15AM	How We Can Strengthen Vaccination Programs and Build Vaccine Confidence Together (ACCESSWIRE)
06:45AM	European Commission Approves Merck's KEYTRUDA (pembrolizumab) Plus Chemotherapy as Neoadjuvant Treatment, Then Continued as Monotherapy as Adjuvant Treatment, for Resectable Non-Small Cell Lung Cancer (NSCLC) at High Risk of Recurrence in Adults (Business Wire)
Mar-27-24 04:36PM	US STOCKS-Stocks close with gains, led by Dow as investors look for rate insight (Reuters)
04:00PM	US STOCKS-Stocks gain, led by Dow as investors look for rate insight (Reuters)
02:58PM	US STOCKS-Dow leads gains on Wall Street as investors await rate clues (Reuters)
12:20PM	US STOCKS-Dow outperforms Wall Street in thin trading week (Reuters)
11:54AM	Merck Stock Hits Record High as FDA Approves Its Cardiovascular Disease Drug (Investopedia)
10:58AM	FDA approves Merck treatment for lung disease, potential path to upside (Yahoo Finance Video)
10:26AM	Stocks to Watch Wednesday: Carnival, Robinhood, Trump Media, Merck (The Wall Street Journal)
10:10AM	US STOCKS-Dow leads Wall St higher in lean trading week (Reuters)
09:53AM	Merck Drug for Rare Form of High Blood Pressure Gets US Nod (Bloomberg)
09:00AM	Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock (Zacks)
08:50AM	US STOCKS-Wall St set to open higher as growth stocks recover (Reuters)
08:39AM	Merck (MRK) Gets FDA Approval for New PAH Drug Winrevair (Zacks)
07:36AM	US STOCKS-Futures tick up in thin trading week, Fed commentary in focus (Reuters)
07:36AM	5 Things to Know Before the Stock Market Opens (Investopedia)
Mar-26-24 06:21PM	FDA Approves Mercks WINREVAIR (sotatercept-csrk), a First-in-Class Treatment for Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1) (Business Wire)
05:07PM	Mercks $11.5 Billion Bet on Its Next Big Drug Finally Arrives (The Wall Street Journal)
01:12PM	FDA approves Merck lung disease drug acquired in $11B deal (BioPharma Dive)
09:30AM	Merck Foundation Strengthens Its Commitment to Expanding Access to Care in Asia-Pacific Region (ACCESSWIRE)
05:15AM	20 Biggest Health Care Companies in Australia, 2024 (Insider Monkey)
Mar-24-24 09:54AM	16 Most Undervalued Growth Stocks To Buy According To Hedge Funds (Insider Monkey)
Mar-22-24 05:45PM	Merck (MRK) Gains As Market Dips: What You Should Know (Zacks)
10:26AM	Merck's (MRK) Keytruda-Lynparza Combo Fails 2nd Lung Cancer Study (Zacks)
Mar-21-24 03:00PM	New Blood Thinners Will Prevent Blood Clots Without Causing Bleeding (The Wall Street Journal)
10:25AM	11 Best Healthcare ETFs To Buy Now (Insider Monkey)
06:45AM	Merck Provides Update on Phase 3 KEYLYNK-006 Trial Evaluating KEYTRUDA (pembrolizumab) Plus Maintenance LYNPARZA (olaparib) for Certain Patients With Metastatic Nonsquamous Non-Small Cell Lung Cancer (Business Wire)
Mar-20-24 05:50PM	Merck (MRK) Laps the Stock Market: Here's Why (Zacks)
Mar-19-24 09:00AM	Merck Announces Positive Data on V116, an Investigational, 21-Valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults, Demonstrated Immune Responses in Adults (Business Wire)
Mar-15-24 04:23PM	FarmSee Ltd Announces the Completion of a Minority Investment in its Swine Monitoring Platform (PR Newswire)
12:17PM	20 States with the Highest Cancer Rates (Insider Monkey)
06:45AM	Mercks KEYTRUDA (pembrolizumab) Plus Chemoradiotherapy (CRT) Significantly Improved Overall Survival (OS) Versus CRT Alone in Patients With Newly Diagnosed High-Risk Locally Advanced Cervical Cancer (Business Wire)
Mar-14-24 07:01PM	Analyst Report: Merck & Co., Inc. (Morningstar Research)
05:45PM	Merck (MRK) Falls More Steeply Than Broader Market: What Investors Need to Know (Zacks)
Mar-13-24 05:50PM	Here's Why Merck (MRK) Fell More Than Broader Market (Zacks)
09:03AM	Analysts on Wall Street Lower Ratings for These 10 Stocks (Insider Monkey)
09:00AM	Is Trending Stock Merck & Co., Inc. (MRK) a Buy Now? (Zacks)
07:01AM	Merck & Co Inc's Dividend Analysis (GuruFocus.com)
03:00AM	Merck Announces Plans to Conduct Clinical Trials of a Novel Investigational Multi-Valent Human Papillomavirus (HPV) Vaccine and Single-Dose Regimen for GARDASIL®9 (Business Wire)
02:45AM	Merck to test single-dose regimen of HPV vaccine Gardasil 9 (Reuters)
Mar-11-24 04:53PM	Moderna stock pops on launch of skin cancer treatment trial (Yahoo Finance Video)
08:15AM	Merck Completes Acquisition of Harpoon Therapeutics, Inc. (Business Wire)
Mar-09-24 12:58PM	13 Best Stocks To Buy and Hold Forever (Insider Monkey)
10:06AM	10 New Alternatives to Antibiotics: Alternative Therapeutic Strategies to Treat Antibiotic-Resistant Pathogens (Insider Monkey)
Mar-06-24 10:25AM	Gilead and Merck Announce Phase 2 Data Showing an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapavir Maintained Viral Suppression at Week 24 (Business Wire)
Mar-05-24 08:30AM	Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments (GlobeNewswire)
06:45AM	Merck to Participate in the Barclays 26th Annual Global Healthcare Conference (Business Wire)
02:56AM	13 Best Pharma Dividend Stocks To Buy in 2024 (Insider Monkey)
Mar-04-24 08:28PM	11 Best Small Cap Pharma Stocks to Invest In (Insider Monkey)
06:45AM	Merck to Participate in the Leerink Partners Global Biopharma Conference 2024 (Business Wire)
Mar-02-24 10:42AM	5 Best Large-Cap Value Stocks To Invest In in 2024 (Insider Monkey)
Mar-01-24 06:14AM	7 Timeless Stocks to Invest in for 2024 (InvestorPlace)
Feb-28-24 06:46PM	21 Countries that Have the Highest Rates of Cancer Deaths (Insider Monkey)
10:17AM	12 Best ESG Dividend Stocks to Buy According to Hedge Funds (Insider Monkey)
09:00AM	Is Most-Watched Stock Merck & Co., Inc. (MRK) Worth Betting on Now? (Zacks)
Feb-27-24 06:45AM	Merck to Participate in the TD Cowen 44th Annual Health Care Conference (Business Wire)
Feb-26-24 01:19PM	14 Best S&P 500 Dividend Stocks To Invest In 2024 (Insider Monkey)
11:29AM	3 Top Pharma Stocks for Investors Betting on a Biotech Boom (InvestorPlace)
Feb-23-24 05:21PM	New York attorney general urges stronger safety warning on asthma drug Singulair (Reuters)
06:20AM	Merck Receives Positive EU CHMP Opinion for KEYTRUDA (pembrolizumab) in Combination With Chemotherapy as Neoadjuvant Treatment, Then Continued as Monotherapy as Adjuvant Treatment, for the Treatment of Resectable NSCLC at High Risk of Recurrence (Business Wire)
05:43AM	20 Fastest Growing Biotech Companies in the US (Insider Monkey)
Feb-22-24 11:22AM	Moderna CEO: 2024 is year of growth, with 2023 transition in rearview (Yahoo Finance)
Feb-20-24 06:45AM	FDA Grants Priority Review to Merck's Application for KEYTRUDA (pembrolizumab) Plus Chemotherapy as Treatment for Primary Advanced or Recurrent Endometrial Carcinoma (Business Wire)
Feb-18-24 04:33PM	15 Best Stocks For Long Term Growth (Insider Monkey)
Feb-16-24 08:30AM	Recession's Shadow Casts Doubt On Soft Landing: Safeguard Your Portfolio With These Stocks (Benzinga)
03:10AM	15 Best Hospitals for Cancer Treatment in the US (Insider Monkey)
Feb-15-24 11:37PM	Merck & Co Inc EVP & CFO Caroline Litchfield Sells 38,291 Shares (GuruFocus.com)
08:45AM	Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032 (GlobeNewswire)
Feb-14-24 10:00AM	Coty Is the Biggest Gainer in the Management Top 250 (The Wall Street Journal)
Feb-13-24 02:16PM	13 Highest Yielding Dividend Stocks in the Dow (Insider Monkey)

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Merck & Co., Inc.	10% Owner	Mar 11 '24	Buy	23.00	21,397,205	492,135,715	1,000	Mar 11 03:27 PM
Davis Robert M	Chairman, CEO & President	Feb 14 '24	Option Exercise	73.73	85,021	6,268,598	433,348	Feb 15 04:01 PM
Litchfield Caroline	EVP & CFO	Feb 14 '24	Option Exercise	58.08	38,291	2,223,941	89,199	Feb 15 04:03 PM
Davis Robert M	Chairman, CEO & President	Feb 14 '24	Sale	125.40	85,021	10,661,574	348,327	Feb 15 04:01 PM
Litchfield Caroline	EVP & CFO	Feb 14 '24	Sale	125.50	38,291	4,805,520	50,908	Feb 15 04:03 PM
Davis Robert M	Chairman, CEO & President	Feb 13 '24	Option Exercise	74.18	150,000	11,127,160	498,327	Feb 15 04:01 PM
Davis Robert M	Chairman, CEO & President	Feb 13 '24	Sale	125.85	150,000	18,877,424	348,327	Feb 15 04:01 PM
Romanelli Joseph	President, Human Health Int?l	Feb 13 '24	Sale	124.89	1,000	124,888	19,569	Feb 14 04:03 PM
Li Dean Y	Executive VP & President, MRL	Feb 09 '24	Option Exercise	62.07	14,702	912,553	60,944	Feb 12 04:03 PM
Li Dean Y	Executive VP & President, MRL	Feb 09 '24	Sale	125.50	14,702	1,845,083	46,242	Feb 12 04:03 PM
Williams David Michael	EVP,Chief Info&Digital Officer	Feb 07 '24	Sale	127.57	1,451	185,108	19,812	Feb 08 04:04 PM
MIZELL STEVEN	EVP, Chief HR Officer	Feb 02 '24	Option Exercise	73.65	32,994	2,430,159	74,313	Feb 02 04:07 PM
Zachary Jennifer	EVP, General Counsel	Feb 02 '24	Option Exercise	87.10	19,417	1,691,221	78,557	Feb 02 04:05 PM
Oosthuizen Johannes Jacobus	President, U.S. Market	Feb 02 '24	Option Exercise	78.80	20,937	1,649,906	42,286	Feb 05 04:01 PM
MIZELL STEVEN	EVP, Chief HR Officer	Feb 02 '24	Sale	126.65	50,694	6,420,349	23,619	Feb 02 04:07 PM
Zachary Jennifer	EVP, General Counsel	Feb 02 '24	Sale	126.97	49,499	6,284,779	29,058	Feb 02 04:05 PM
Oosthuizen Johannes Jacobus	President, U.S. Market	Feb 02 '24	Sale	127.17	18,959	2,411,111	23,327	Feb 05 04:01 PM
Oosthuizen Johannes Jacobus	President, U.S. Market	Nov 09 '23	Sale	102.38	2,081	213,061	18,191	Nov 13 07:36 AM
DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Nov 08 '23	Sale	105.03	43,823	4,602,668	111,764	Nov 09 09:04 AM
Oosthuizen Johannes Jacobus	President, U.S. Market	Oct 30 '23	Option Exercise	102.82	915	94,080	20,723	Oct 31 11:08 AM
MIZELL STEVEN	EVP, Chief HR Officer	Aug 14 '23	Sale	109.01	4,250	463,292	22,935	Aug 15 04:08 PM
Guindo Chirfi	Chief Marketing Officer	Aug 03 '23	Option Exercise	105.70	36,901	3,900,436	38,342	Aug 04 04:17 PM
MIZELL STEVEN	EVP, Chief HR Officer	Aug 03 '23	Sale	105.49	4,500	474,701	27,185	Aug 04 04:06 PM
Romanelli Joseph	President, Human Health Int?l	Aug 02 '23	Sale	107.37	59	6,335	0	Aug 03 04:08 PM
Romanelli Joseph	President, Human Health Int?l	Aug 02 '23	Sale	107.37	30	3,221	20,569	Aug 03 04:08 PM
Karachun Rita A	Sr. VP Fince-Global Controller	May 04 '23	Option Exercise	65.24	16,824	1,097,552	61,585	May 05 04:54 PM
Oosthuizen Johannes Jacobus	President, U.S. Market	May 04 '23	Option Exercise	118.22	907	107,226	20,207	May 05 05:09 PM
Klobuchar Michael A	EVP - Chief Strategy Officer	May 04 '23	Option Exercise	118.22	885	104,625	19,476	May 05 05:06 PM
LeCointe-Cephas Lisa	SVP Chief Ethics & Com Officer	May 04 '23	Option Exercise	118.22	813	96,113	5,421	May 05 05:01 PM
Zachary Jennifer	EVP, General Counsel	May 04 '23	Sale	117.59	19,141	2,250,834	35,128	May 05 05:13 PM
Karachun Rita A	Sr. VP Fince-Global Controller	May 04 '23	Sale	117.53	15,875	1,865,843	45,710	May 05 04:54 PM
MIZELL STEVEN	EVP, Chief HR Officer	May 03 '23	Option Exercise	75.55	52,000	3,928,540	73,085	May 05 05:19 PM
Karachun Rita A	Sr. VP Fince-Global Controller	May 03 '23	Option Exercise	117.89	803	94,666	45,363	May 05 04:54 PM
LeCointe-Cephas Lisa	SVP Chief Ethics & Com Officer	May 03 '23	Option Exercise	117.89	689	81,226	4,844	May 05 05:01 PM
MIZELL STEVEN	EVP, Chief HR Officer	May 03 '23	Sale	119.01	53,400	6,355,056	31,685	May 05 05:19 PM
Williams David Michael	EVP,Chief Info&Digital Officer	May 02 '23	Option Exercise	56.04	6,035	338,201	18,568	May 03 04:29 PM
Williams David Michael	EVP,Chief Info&Digital Officer	May 02 '23	Sale	116.82	7,509	877,222	11,059	May 03 04:29 PM
DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	May 01 '23	Option Exercise	56.04	75,436	4,227,433	229,929	May 02 11:37 AM
Li Dean Y	Executive VP & President, MRL	May 01 '23	Option Exercise	115.47	1,062	122,629	20,995	May 03 04:10 PM
Karachun Rita A	Sr. VP Fince-Global Controller	May 01 '23	Option Exercise	115.47	930	107,387	44,879	May 03 04:24 PM
Oosthuizen Johannes Jacobus	President, U.S. Market	May 01 '23	Option Exercise	115.47	866	99,997	19,727	May 03 03:54 PM
Klobuchar Michael A	EVP - Chief Strategy Officer	May 01 '23	Option Exercise	115.47	866	99,997	18,901	May 03 03:00 PM
Litchfield Caroline	EVP & CFO	May 01 '23	Option Exercise	115.47	866	99,997	32,118	May 03 04:07 PM
LeCointe-Cephas Lisa	SVP Chief Ethics & Com Officer	May 01 '23	Option Exercise	115.47	643	74,247	4,376	May 03 03:11 PM
Williams David Michael	EVP,Chief Info&Digital Officer	May 01 '23	Option Exercise	115.47	577	66,626	12,731	May 03 04:29 PM
DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	May 01 '23	Sale	116.03	75,436	8,752,749	154,493	May 02 11:37 AM
Davis Robert M	Chairman, CEO & President	Apr 28 '23	Option Exercise	56.04	143,329	8,032,157	415,146	Apr 28 05:15 PM
DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Apr 28 '23	Option Exercise	62.07	66,163	4,106,737	220,656	May 02 11:37 AM
Davis Robert M	Chairman, CEO & President	Apr 28 '23	Sale	114.93	143,329	16,472,845	271,817	Apr 28 05:15 PM
DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Apr 28 '23	Sale	115.00	66,163	7,608,844	154,493	May 02 11:37 AM
Romanelli Joseph	President, Human Health Int?l	Apr 26 '23	Buy	113.68	3	341	20,599	Jun 30 04:04 PM

Open in Screener

BR

Broadridge Financial Solutions, Inc.

Apr 24 • 04:00PM ET

195.08

Dollar change -0.83
Percentage change -0.42	%

Technology • Information Technology Services • USA • NYSE

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

BR Broadridge Financial Solutions, Inc. daily Stock Chart

Held by: VTI VOO VO IVV VUG VOT VIG RSP IWP IWR

Index	S&P 500	P/E	33.98	EPS (ttm)	5.74	Insider Own	0.69%	Shs Outstand	118.10M	Perf Week	0.84%
Market Cap	22.97B	Forward P/E	22.87	EPS next Y	8.53	Insider Trans	-11.87%	Shs Float	116.96M	Perf Month	-3.59%
Income	683.80M	PEG	2.88	EPS next Q	2.24	Inst Own	92.19%	Short Float	0.75%	Perf Quarter	-5.33%
Sales	6.32B	P/S	3.63	EPS this Y	10.41%	Inst Trans	0.24%	Short Ratio	1.63	Perf Half Y	12.99%
Book/sh	17.57	P/B	11.11	EPS next Y	10.21%	ROA	8.52%	Short Interest	0.87M	Perf Year	34.83%
Cash/sh	2.36	P/C	82.73	EPS next 5Y	11.80%	ROE	35.48%	52W Range	139.52 - 210.24	Perf YTD	-5.19%
Dividend Est.	3.17 (1.62%)	P/FCF	23.13	EPS past 5Y	8.32%	ROI	11.58%	52W High	-7.21%	Beta	0.98
Dividend TTM	3.13 (1.60%)	Quick Ratio	1.40	Sales past 5Y	6.65%	Gross Margin	29.93%	52W Low	39.82%	ATR (14)	2.93
Dividend Ex-Date	Mar 14, 2024	Current Ratio	1.40	EPS Y/Y TTM	27.60%	Oper. Margin	16.49%	RSI (14)	41.46	Volatility	1.13% 1.38%
Employees	14700	Debt/Eq	1.87	Sales Y/Y TTM	8.30%	Profit Margin	10.82%	Recom	2.33	Target Price	212.67
Option/Short	Yes / Yes	LT Debt/Eq	1.86	EPS Q/Q	22.06%	Payout	54.73%	Rel Volume	0.48	Prev Close	195.91
Sales Surprise	0.19%	EPS Surprise	3.04%	Sales Q/Q	8.67%	Earnings	May 08 BMO	Avg Volume	533.44K	Price	195.08
SMA20	-2.25%	SMA50	-2.69%	SMA200	3.19%	Trades		Volume	255,804	Change	-0.42%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-17-23	Upgrade	Wolfe Research	Underperform → Peer Perform
Apr-24-23	Initiated	RBC Capital Mkts	Outperform	$169
Dec-14-22	Initiated	Morgan Stanley	Equal-Weight	$160
Aug-13-21	Resumed	JP Morgan	Overweight	$181
Feb-03-21	Upgrade	BTIG Research	Neutral → Buy	$176
Dec-18-20	Initiated	Truist	Buy	$175
Aug-12-20	Downgrade	BTIG Research	Buy → Neutral
Aug-05-20	Downgrade	DA Davidson	Buy → Neutral
Feb-28-20	Upgrade	Raymond James	Mkt Perform → Outperform	$130
Feb-26-20	Initiated	BTIG Research	Buy	$135
Feb-03-20	Upgrade	DA Davidson	Neutral → Buy	$134 → $138
Jul-31-19	Downgrade	Raymond James	Outperform → Mkt Perform
May-08-19	Downgrade	DA Davidson	Buy → Neutral	$128
Mar-13-19	Upgrade	Raymond James	Mkt Perform → Outperform	$118
Feb-08-19	Upgrade	DA Davidson	Neutral → Buy	$116
Aug-29-18	Initiated	SunTrust	Buy	$150
Sep-29-16	Downgrade	Sandler O'Neill	Buy → Hold
Jul-07-16	Downgrade	Barclays	Overweight → Equal Weight	$67
Jun-15-16	Downgrade	Avondale	Mkt Outperform → Mkt Perform
Jun-07-16	Downgrade	Raymond James	Outperform → Mkt Perform

Show Previous Ratings

Apr-19-24 05:13PM	Broadridge Schedules Webcast and Conference Call to Review Third Quarter Fiscal Year 2024 Results on May 8, 2024 (PR Newswire)
Apr-16-24 09:45AM	Why Broadridge Financial Solutions (BR) is a Top Growth Stock for the Long-Term (Zacks)
05:33AM	Here's Why Broadridge Financial Solutions (BR) is in Detractor's List of Ensemble Capital (Insider Monkey)
Apr-15-24 09:30AM	Earnings Growth & Price Strength Make Broadridge Financial Solutions (BR) a Stock to Watch (Zacks)
Apr-14-24 07:00PM	SBI SECURITIES Selects Broadridge's Post-trade Solution for its Equities Brokerage Services in the UK (PR Newswire)
07:00AM	Loading…
Apr-11-24 07:00AM	Broadridge Names Hope Jarkowski Chief Legal Officer (PR Newswire)
Apr-08-24 07:00AM	Frank Troise Joins Broadridge to Lead Trading and Connectivity Solutions Business (PR Newswire)
Apr-05-24 12:03PM	Reasons Why You Should Bet on Broadridge (BR) Stock Now (Zacks)
Apr-03-24 04:30PM	The 3 Best Financial Services Stocks to Buy in April 2024 (InvestorPlace)
Mar-27-24 03:00AM	Across Europe Retail Investor Voting Activity is Growing, According to New Broadridge Whitepaper (PR Newswire)
Mar-26-24 04:00AM	Vanguard Unseats BlackRock's Top Spot in Broadridge's 2024 Best-Performing Fund Brand Ranking in the U.S. (PR Newswire)
04:00AM	Best-Performing Fund Brands in Europe and Globally According to the 2024 Broadridge Fund Brand 50 Report (PR Newswire)
Mar-25-24 07:00AM	LTX by Broadridge Integrates with TS Imagine to Improve Fixed Income Liquidity Access for Mutual Buy-Side Clients (PR Newswire)
03:00AM	Broadridge's New Investor Insights Solution Elevates Engagement Between Issuers and Investors (PR Newswire)
Mar-22-24 10:19AM	Broadridge (BR) Rises 52% in a Year: What You Should Know (Zacks)
03:00AM	Loading…
Mar-21-24 03:00AM	Baader Bank Chooses Broadridge's Platform for Regulatory Trade and Transaction Reporting (PR Newswire)
Mar-20-24 11:52AM	Here's Why Investors Should Retain Broadridge (BR) Stock Now (Zacks)
Mar-19-24 06:01PM	Analyst Report: Broadridge Financial Solutions, Inc. (Morningstar Research)
08:34AM	Board and C-Suite Leaders Diverge on How to Address Critical Business Challenges, Study from Protiviti, Broadridge and BoardProspects Finds (PR Newswire)
Mar-15-24 12:36PM	Wall Streets Model-Portfolio Boom May Hit $11 Trillion by 2028 (Bloomberg)
Mar-14-24 07:53AM	/C O R R E C T I O N -- Broadridge Financial Solutions, Inc./ (PR Newswire)
04:00AM	Gap Widens Between Leaders and Non-Leaders as Digital Transformation in Financial Services Reaches New Level of Maturity (PR Newswire)
Mar-12-24 09:30AM	Why Broadridge Financial Solutions (BR) is a Top Stock for the Long-Term (Zacks)
07:00AM	Broadridge Launches Global Futures and Options Fully Hosted Trading Platform to Expand Derivatives Trading Capabilities (PR Newswire)
Mar-11-24 12:18PM	13 Countries with the Best Citizenship by Investment Program in the World (Insider Monkey)
Mar-10-24 07:00PM	Matsui Securities Adopts Broadridge's Post Trade Solution to Drive Stock Lending Efficiency (PR Newswire)
Mar-07-24 05:00PM	Insider Sell: Co-President ICS Douglas Deschutter Sells 12,200 Shares of Broadridge Financial ... (GuruFocus.com)
Mar-05-24 09:45AM	Here's Why Broadridge Financial Solutions (BR) is a Strong Growth Stock (Zacks)
Mar-04-24 07:26PM	Analyst Report: Broadridge Financial Solutions, Inc. (Morningstar Research)
Mar-03-24 07:30PM	CGS International Securities Expands Securities Finance Capabilities with Broadridge SFCM Solution (PR Newswire)
03:00AM	Loading…
Feb-27-24 03:00AM	Broadridge Whitepaper Highlights the Drive for Efficiency Amongst Nordic Capital Markets Firms (PR Newswire)
Feb-22-24 05:00PM	Broadridge to Participate in Upcoming Investor Events (PR Newswire)
Feb-20-24 09:18AM	Navigating the CX Challenge: Despite Companies' Increased Tech Investments, Consumer Impatience Grows (PR Newswire)
Feb-16-24 09:51AM	Broadridge Declares Quarterly Dividend of $0.80 Per Share (PR Newswire)
Feb-15-24 07:00AM	Global Class Action Mega-Settlements Smash Four-Year Average by Over 87% New Broadridge Report Shows (PR Newswire)
Feb-13-24 07:35PM	Analyst Report: Broadridge Financial Solutions, Inc. (Morningstar Research)
Feb-09-24 04:15AM	The London Company SMID Cap Strategy Reduced Broadridge Financial Solutions (BR) on Strength (Insider Monkey)
Feb-08-24 03:02PM	Broadridge Financial Solutions Inc Co-President ICS Douglas Deschutter Sells 22,722 Shares (GuruFocus.com)
Feb-07-24 09:45AM	Why Broadridge Financial Solutions (BR) is a Top Growth Stock for the Long-Term (Zacks)
07:30AM	Fifth Annual Broadridge Survey Reveals Time and Expertise Top Challenges in Advisor Marketing Strategies (PR Newswire)
Feb-02-24 03:50PM	Dual Citizenship Advantages, Disadvantages, and Requirements (Insider Monkey)
11:05AM	Broadridge Financial Solutions, Inc. (NYSE:BR) Q2 2024 Earnings Call Transcript (Insider Monkey)
12:11AM	Beyond the Balance Sheet: What SWOT Reveals About Broadridge Financial Solutions Inc (BR) (GuruFocus.com)
Feb-01-24 11:15PM	Q2 2024 Broadridge Financial Solutions Inc Earnings Call (Thomson Reuters StreetEvents)
02:46PM	Analyst Report: Broadridge Financial Solutions, Inc. (Morningstar Research)
01:01PM	Broadridge's (BR) Q2 Earnings Beat Estimates, Increase Y/Y (Zacks)
12:59PM	Broadridge Financial Solutions Inc (BR) Reports Solid Q2 Fiscal 2024 Results (GuruFocus.com)
09:30AM	Broadridge Financial (BR) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
08:10AM	Broadridge Financial Solutions (BR) Beats Q2 Earnings and Revenue Estimates (Zacks)
07:49AM	Broadridge Financial profit rises on strength in investor communication services unit (Reuters)
07:06AM	Broadridge Financial: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	Broadridge Reports Second Quarter Fiscal 2024 Results (PR Newswire)
Jan-31-24 12:13PM	Exchange Data International Data Now Available with Broadridge's Asset Servicing Solution to Inform Decision Making and Improve Customer Choice (GlobeNewswire)
07:30AM	Broadridge Recognized as One of FORTUNE Magazine's 2024 'World's Most Admired Companies' (PR Newswire)
07:00AM	Silverview Credit Partners Optimizes Investment Operations with Broadridge's Private Debt Portfolio Management Solution (PR Newswire)
Jan-30-24 10:53AM	Broadridge (BR) to Report Q2 Earnings: What's in the Cards? (Zacks)
Jan-29-24 09:16AM	Unveiling Broadridge Financial (BR) Q2 Outlook: Wall Street Estimates for Key Metrics (Zacks)
07:30AM	LTX by Broadridge Announces Four New Patents Covering Fixed Income Trading Innovations (PR Newswire)
Jan-22-24 09:30AM	Earnings Growth & Price Strength Make Broadridge Financial Solutions (BR) a Stock to Watch (Zacks)
Jan-18-24 04:45PM	Broadridge Schedules Webcast and Conference Call to Review Second Quarter Fiscal Year 2024 Results on February 1, 2024 (PR Newswire)
07:30AM	Chad Alderson Joins Broadridge Canada as General Manager, Global Technology and Operations (PR Newswire)
07:28AM	Broadridge Financial Solutions (BR) Used AI to Enhance Productivity (Insider Monkey)
Jan-11-24 07:30AM	Broadridge Launches GenAI-Powered OpsGPT to Transform and Optimize Trading in a T+1 Environment (PR Newswire)
07:00AM	AI Tool Helps Fix Faulty Trades Amid Shift to Faster Settlement Times (Bloomberg)
03:00AM	Broadridge and Boring Money Collaborate to Deliver Consumer Duty Solution for Asset Managers (PR Newswire)
Jan-04-24 11:15AM	Why Broadridge Financial (BR) Deserves to be in Your Portfolio (Zacks)
Jan-02-24 05:30AM	As CFOs Prepare for an Unpredictable 2024, Heres What Tops Their Checklists (The Wall Street Journal)
Dec-28-23 07:23PM	Analyst Report: Broadridge Financial Solutions, Inc. (Morningstar Research)
Dec-26-23 10:12PM	Broadridge Financial Solutions Inc Insider Sells Company Shares (GuruFocus.com)
Dec-19-23 12:00PM	Broadridge Financial Solutions (BR) is a Great Momentum Stock: Should You Buy? (Zacks)
Dec-15-23 09:30AM	Why Broadridge Financial Solutions (BR) is a Top Stock for the Long-Term (Zacks)
Dec-14-23 11:55AM	Broadridge (BR) Rises 33% in a Year: What You Should Know (Zacks)
Dec-13-23 04:00AM	TMF Group Adopts Broadridge's Sentry Loan Administration Platform to Scale for Private Debt and CLO Fund Services Business Growth (PR Newswire)
Dec-12-23 04:02PM	3 Mid-Cap Stocks to Buy for Their Big-Time Dividends (InvestorPlace)
Dec-08-23 08:30PM	KBW Announces Index Rebalancing for Fourth-Quarter 2023 (GlobeNewswire)
03:19PM	Broadridges Next 3 Years Should Look Like Its Last 3. Its a Strong Case for the Stock. (Barrons.com)
Dec-07-23 07:00AM	Broadridge Highlights Path for Sustainable Long-term Growth at Investor Day 2023 (PR Newswire)
Dec-04-23 09:30AM	Why Broadridge Financial Solutions (BR) is a Top Stock for the Long-Term (Zacks)
03:00AM	Broadridge Investment Management Technology Enhances Carlyle's Private Credit and CLO Portfolio Management Operations (PR Newswire)
Dec-02-23 09:04AM	Insider Sell: President Christopher Perry Sells 18,091 Shares of Broadridge Financial Solutions ... (GuruFocus.com)
Nov-27-23 08:00AM	Broadridge to Host Investor Day on December 7, 2023 (PR Newswire)
Nov-23-23 09:30AM	Why Broadridge Financial Solutions (BR) is a Top Stock for the Long-Term (Zacks)
Nov-22-23 07:26PM	Analyst Report: Broadridge Financial Solutions, Inc. (Morningstar Research)
Nov-17-23 12:16PM	Reasons Why You Should Bet on Broadridge (BR) Stock Now (Zacks)
Nov-15-23 07:00AM	HSBC Next Client to Go Live on Broadridge's Newly Launched Distributed Ledger Sponsored Repo Solution (PR Newswire)
Nov-09-23 12:33PM	Broadridge Declares Quarterly Dividend of $0.80 Per Share (PR Newswire)
02:00AM	Broadridge Expands Shareholder Disclosure Solution to UK, Australia and Hong Kong Markets (PR Newswire)
Nov-07-23 03:00AM	Broadridge Launches Two AI-Enabled Tools to Optimize Product, Strategy and Distribution Decision Making for Asset Managers (PR Newswire)
Nov-06-23 08:00AM	Morningstar Investment Management & Envestnet Team Up to Deliver Personalized IRAs (PR Newswire)
Nov-03-23 09:45AM	Broadridge Financial Solutions, Inc. (NYSE:BR) Q1 2024 Earnings Call Transcript (Insider Monkey)
06:04AM	Broadridge Financial Solutions (BR) Rose on Stronger Than Expected Guidance (Insider Monkey)
01:09AM	The Broadridge Financial Solutions Inc (BR) Company: A Short SWOT Analysis (GuruFocus.com)
Nov-02-23 11:12PM	Q1 2024 Broadridge Financial Solutions Inc Earnings Call (Thomson Reuters StreetEvents)
03:22PM	Analyst Report: Broadridge Financial Solutions, Inc. (Morningstar Research)
01:52PM	Broadridge's (BR) Q1 Earnings Beat Estimates, Increase Y/Y (Zacks)
09:30AM	Broadridge Financial (BR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
08:25AM	Broadridge Financial Solutions (BR) Beats Q1 Earnings and Revenue Estimates (Zacks)
07:29AM	Broadridge Financial: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
07:00AM	Broadridge Reports First Quarter Fiscal 2024 Results (PR Newswire)
Nov-01-23 01:19PM	Service Stocks' Nov 2 Earnings Roster: BR, APTV & PLTR (Zacks)

Broadridge Financial Solutions, Inc. engages in the provision of investor communications and technology solutions to banks, broker-dealers, mutual funds, and corporate issuers. It operates through the following segments: Investor Communication Solutions and Global Technology and Operations. The Investor Communication Solutions segment offers services for broker-dealer investor communication, customer communication, corporate issuer, advisor solutions, and mutual fund and retirement solutions. The Global Technology and Operations segment includes middle and back-office securities processing solutions, automation services, and business process outsourcing services. The company was founded in 1962 and is headquartered in Lake Success, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DESCHUTTER DOUGLAS RICHARD	Co-President ICS	Mar 07 '24	Sale	204.71	12,200	2,497,474	32,480	Mar 07 02:27 PM
Duelks Robert N	Director	Feb 29 '24	Sale	201.58	830	167,311	5,445	Mar 04 05:18 PM
Carey Thomas P	Corporate VP	Feb 28 '24	Option Exercise	98.31	14,712	1,446,337	26,034	Feb 28 01:20 PM
Carey Thomas P	Corporate VP	Feb 28 '24	Sale	201.02	12,731	2,559,131	13,303	Feb 28 01:20 PM
DESCHUTTER DOUGLAS RICHARD	Co-President ICS	Feb 06 '24	Option Exercise	50.95	27,778	1,415,289	67,402	Feb 08 10:44 AM
DESCHUTTER DOUGLAS RICHARD	Co-President ICS	Feb 06 '24	Sale	199.00	22,722	4,521,685	44,680	Feb 08 10:44 AM
PERRY CHRISTOPHER JOHN	President	Dec 28 '23	Option Exercise	148.07	5,438	805,205	64,720	Dec 28 01:52 PM
PERRY CHRISTOPHER JOHN	President	Dec 28 '23	Sale	205.32	5,069	1,040,752	59,651	Dec 28 01:52 PM
PERRY CHRISTOPHER JOHN	President	Dec 26 '23	Option Exercise	148.07	7,094	1,050,409	65,925	Dec 26 12:35 PM
PERRY CHRISTOPHER JOHN	President	Dec 26 '23	Sale	200.17	6,643	1,329,702	59,282	Dec 26 12:35 PM
PERRY CHRISTOPHER JOHN	President	Dec 22 '23	Option Exercise	148.07	2,906	430,291	61,553	Dec 26 12:35 PM
PERRY CHRISTOPHER JOHN	President	Dec 22 '23	Sale	200.01	2,722	544,420	58,831	Dec 26 12:35 PM
Matlin Laura	CVP, Deputy GC and CCO	Dec 08 '23	Option Exercise	93.88	4,178	392,231	10,571	Dec 11 01:33 PM
Matlin Laura	CVP, Deputy GC and CCO	Dec 08 '23	Sale	189.49	4,090	775,019	6,481	Dec 11 01:33 PM
PERRY CHRISTOPHER JOHN	President	Dec 01 '23	Option Exercise	117.34	20,000	2,346,800	76,738	Dec 01 04:03 PM
PERRY CHRISTOPHER JOHN	President	Dec 01 '23	Sale	193.82	18,091	3,506,372	58,647	Dec 01 04:03 PM
Gumbs Keir D	CVP and Chief Legal Officer	Nov 09 '23	Option Exercise	144.84	4,151	601,231	18,174	Nov 09 04:54 PM
Gumbs Keir D	CVP and Chief Legal Officer	Nov 09 '23	Sale	176.61	3,771	665,993	14,403	Nov 09 04:54 PM
PERRY CHRISTOPHER JOHN	President	Nov 08 '23	Sale	176.94	20,614	3,647,480	56,738	Nov 09 01:00 PM
SCHIFELLITE ROBERT	Corporate SVP	Sep 19 '23	Option Exercise	118.47	70,181	8,314,574	123,576	Sep 20 04:42 PM
Gokey Timothy C	CEO	Sep 06 '23	Option Exercise	50.95	72,222	3,679,711	237,187	Sep 07 04:40 PM
Gokey Timothy C	CEO	Sep 06 '23	Sale	185.63	59,341	11,015,387	177,846	Sep 07 04:40 PM
PERRY CHRISTOPHER JOHN	President	Aug 30 '23	Option Exercise	111.09	14,236	1,581,449	90,186	Sep 01 10:34 AM
PERRY CHRISTOPHER JOHN	President	Aug 30 '23	Sale	186.45	12,834	2,392,942	77,352	Sep 01 10:34 AM
Gumbs Keir D	CVP and Chief Legal Officer	Aug 30 '23	Sale	186.41	2,688	501,079	14,023	Sep 01 09:57 AM
DALY RICHARD J	Executive Chairman	Aug 28 '23	Sale	185.40	8,297	1,538,268	111,721	Aug 29 11:37 AM
Carey Thomas P	Corporate VP	Aug 22 '23	Sale	178.40	2,500	445,994	11,322	Aug 23 10:33 AM
DALY RICHARD J	Executive Chairman	Aug 21 '23	Option Exercise	108.62	80,307	8,723,300	192,068	Aug 22 03:58 PM
DALY RICHARD J	Executive Chairman	Aug 21 '23	Sale	178.29	72,050	12,846,068	120,018	Aug 22 03:58 PM
DALY RICHARD J	Executive Chairman	Aug 18 '23	Sale	178.82	31,565	5,644,343	111,761	Aug 21 02:15 PM
DALY RICHARD J	Executive Chairman	Aug 18 '23	Sale	179.11	19,484	3,489,685	0	Aug 21 02:15 PM
Gumbs Keir D	CVP and Chief Legal Officer	Aug 16 '23	Option Exercise	0.00	4,848	0	19,041	Aug 17 02:59 PM
DESCHUTTER DOUGLAS RICHARD	Corporate Vice President	Aug 14 '23	Option Exercise	50.95	27,777	1,415,238	61,121	Aug 15 01:42 PM
DESCHUTTER DOUGLAS RICHARD	Corporate Vice President	Aug 14 '23	Sale	182.95	22,874	4,184,750	38,247	Aug 15 01:42 PM
BRUN LESLIE A	Director	Aug 11 '23	Sale	181.20	2,000	362,407	72,430	Aug 15 03:52 PM
SCHIFELLITE ROBERT	Corporate SVP	Aug 10 '23	Option Exercise	93.88	23,877	2,241,573	74,191	Aug 11 02:29 PM
PERRY CHRISTOPHER JOHN	President	Aug 10 '23	Option Exercise	98.31	11,381	1,118,866	79,483	Aug 11 12:32 PM
SCHIFELLITE ROBERT	Corporate SVP	Aug 10 '23	Sale	179.27	26,109	4,680,461	48,082	Aug 11 02:29 PM
PERRY CHRISTOPHER JOHN	President	Aug 10 '23	Sale	180.57	10,118	1,826,975	69,365	Aug 11 12:32 PM
PERRY CHRISTOPHER JOHN	President	Aug 09 '23	Option Exercise	98.31	2,181	214,414	70,041	Aug 11 12:32 PM
PERRY CHRISTOPHER JOHN	President	Aug 09 '23	Sale	180.09	1,939	349,189	68,102	Aug 11 12:32 PM
BRUN LESLIE A	Director	Jun 02 '23	Option Exercise	36.35	14,396	523,295	74,312	Jun 05 01:21 PM
Duelks Robert N	Director	Jun 01 '23	Option Exercise	36.35	10,841	394,070	44,476	Jun 01 05:10 PM
BRUN LESLIE A	Director	Jun 01 '23	Option Exercise	36.35	1,866	67,829	66,816	Jun 01 05:10 PM
BRUN LESLIE A	Director	Jun 01 '23	Sale	148.98	6,900	1,027,952	59,916	Jun 01 05:10 PM
Matlin Laura	VP, Deputy GC and CGO	May 19 '23	Option Exercise	67.32	4,725	318,087	9,877	May 22 02:07 PM
Matlin Laura	VP, Deputy GC and CGO	May 19 '23	Sale	153.73	4,052	622,913	5,825	May 22 02:07 PM
Duelks Robert N	Director	May 05 '23	Sale	154.34	1,200	185,214	33,635	May 05 02:44 PM
KALENKA ROBERT F	Corporate Vice President	May 04 '23	Option Exercise	96.17	17,289	1,662,660	43,921	May 05 01:41 PM
SCHIFELLITE ROBERT	Corporate SVP	May 04 '23	Option Exercise	67.32	12,397	834,566	66,009	May 04 05:12 PM
KALENKA ROBERT F	Corporate Vice President	May 04 '23	Sale	152.63	17,433	2,660,729	26,488	May 05 01:41 PM
SCHIFELLITE ROBERT	Corporate SVP	May 04 '23	Sale	152.59	15,695	2,394,887	50,314	May 04 05:12 PM
Stingi Richard John	Corporate VP and CHRO	May 04 '23	Sale	155.27	750	116,450	4,202	May 04 04:58 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

MRK

Merck & Co Inc

BR

Broadridge Financial Solutions, Inc.

Upgrade your FINVIZ experience